Other Events ·
Apnimed, Inc. filed its ninth amended and restated certificate of incorporation with the Delaware Secretary of State…
APMDApnimed, Inc.
Apnimed, Inc. filed its ninth amended and restated certificate of incorporation with the Delaware Secretary of State on August 3, 2026, in connection with the consummation of its initial public offering. The Restated Certificate authorizes 500,000,000 shares of common stock, eliminates references to previously existing preferred stock series, and authorizes 10,000,000 shares of undesignated preferred stock issuable at the Board's discretion. Concurrently, the second amended and restated bylaws became effective, establishing procedures for stockholder actions, advance notice requirements for proposals and director nominations, and conforming to the Restated Certificate provisions. Apnimed, Inc. operates in the biotechnology industry, focusing on the development of novel therapies.